Literature DB >> 3512509

Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

S I Rennard, G Basset, D Lecossier, K M O'Donnell, P Pinkston, P G Martin, R G Crystal.   

Abstract

Bronchoalveolar lavage is a powerful technique for sampling the epithelial lining fluid (ELF) of the lower respiratory tract but also results in a significant dilution of that fluid. To quantify the apparent volume of ELF obtained by bronchoalveolar lavage, urea was used as an endogenous marker of ELF dilution. Since urea diffuses readily through the body, plasma and in situ ELF urea concentrations are identical; thus ELF volume can be calculated using simple dilution principles. Using this approach, we determined that with a standard lavage procedure, the volume of ELF recovered from a normal human is 1.0 +/- 0.1 ml/100 ml of recovered lavage fluid. Time course experiments in which the saline used for lavage was permitted to remain in the lower respiratory tract for various "dwell times" suggested that diffusion of urea from sources other than recovered ELF can contribute to the total urea recovered resulting in an overestimate of the volume of ELF recovered. Thus, while reasonably accurate, the volume of ELF determined by urea must be considered an overestimate, or "apparent" volume. The ELF albumin concentration based on the apparent ELF volume was 3.7 +/- 0.3 mg/ml, a value that is in good agreement with direct measurements made by other techniques in experimental animals. The density of all inflammatory and immune effector cells on the epithelial surface of the lower respiratory tract, based on the apparent ELF volume, was 21,000 +/- 3,000 cells/microliter, a value that is twofold greater than that in blood.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512509     DOI: 10.1152/jappl.1986.60.2.532

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  313 in total

1.  Formulation and physical characterization of large porous particles for inhalation.

Authors:  R Vanbever; J D Mintzes; J Wang; J Nice; D Chen; R Batycky; R Langer; D A Edwards
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

Review 2.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

3.  Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.

Authors:  J E Conte; J A Golden; M McQuitty; J Kipps; E T Lin; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation.

Authors:  A W Peng; S Milleri; D S Stein
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers.

Authors:  Jun-Ichi Kadota; Yuji Ishimatsu; Tetsuji Iwashita; Yuichi Matsubara; Kazunori Tomono; Masao Tateno; Roza Ishihara; Claudette Muller-Serieys; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 6.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Pulmonary disposition of vancomycin in critically ill patients.

Authors:  H Georges; O Leroy; S Alfandari; B Guery; M Roussel-Delvallez; C Dhennain; G Beaucaire
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

8.  Pulmonary oxidative stress response in young children with cystic fibrosis.

Authors:  J Hull; P Vervaart; K Grimwood; P Phelan
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

9.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

Authors:  Timothy W Shipley; Heather M Kling; Alison Morris; Sangita Patil; Jan Kristoff; Siobhan E Guyach; Jessica E Murphy; Xiuping Shao; Frank C Sciurba; Robert M Rogers; Thomas Richards; Paul Thompson; Ronald C Montelaro; Harvey O Coxson; James C Hogg; Karen A Norris
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

10.  TGF-β directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury.

Authors:  Dorothea M Peters; István Vadász; Lukasz Wujak; Malgorzata Wygrecka; Andrea Olschewski; Christin Becker; Susanne Herold; Rita Papp; Konstantin Mayer; Sebastian Rummel; Ralph P Brandes; Andreas Günther; Siegfried Waldegger; Oliver Eickelberg; Werner Seeger; Rory E Morty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.